Literature DB >> 22543849

Apathy and depression in mild Alzheimer's disease: a cross-sectional study using diagnostic criteria.

Michel Benoit1, Gilles Berrut, Johanna Doussaint, Serge Bakchine, Sylvie Bonin-Guillaume, Patrick Frémont, Thierry Gallarda, Pierre Krolak-Salmon, Thierry Marquet, Claude Mékiès, François Sellal, Stéphane Schuck, Renaud David, Philippe Robert.   

Abstract

Apathy and depression are the most frequent neuropsychiatric symptoms in Alzheimer's disease (AD). In a cross-sectional observational study of 734 subjects with probable mild AD, we evaluated the prevalence of apathy and depression. After the use of specific diagnostic criteria, we tested the interaction between the two syndromes and their relation with specific comorbidities, and different functional outcomes. Depression was diagnosed using the diagnostic criteria for depression in AD, and apathy with the diagnostic criteria for apathy in neuropsychiatric disorders. According to the specific diagnostic criteria, depression had a 47.9% prevalence, while apathy prevalence was 41.6%. Apathy and depression were associated in 32.4% of patients (n = 225). 9.4% (n = 65) had only apathy, 15.4% (n = 107) had only depression, and 42.9% had no apathy and no depression (n = 298). The three most frequent depressive symptoms were fatigue or loss of energy (59.4%), decreased positive affect or pleasure in response to social contacts and activities (46.2%), and psychomotor agitation or retardation (36.9%). Concerning apathy, loss of goal-directed cognition was the most frequently altered (63.6%), followed by loss of goal-directed action (60.6%) and loss of goal-directed emotion (43.8%). Patients with both apathy and depression more frequently required a resource allowance for dependency. Neurological comorbidities were more frequent in the "apathy and depression" and "depression alone" groups (p < 0.001). Apathy and depression overlap considerably, and this might be explained by the presence of some non-specific symptoms in both diagnostic criteria. The need for social support is higher when a patient fulfills the two diagnostic criteria.

Entities:  

Mesh:

Year:  2012        PMID: 22543849     DOI: 10.3233/JAD-2012-112003

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

1.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

Review 2.  Body mass index and mild cognitive impairment-to-dementia progression in 24 months: a prospective study.

Authors:  T Sobów; W Fendler; R Magierski
Journal:  Eur J Clin Nutr       Date:  2014-08-13       Impact factor: 4.016

3.  Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.

Authors:  Patricia Szot; Allyn Franklin; Cristina Miguelez; Yangqing Wang; Igor Vidaurrazaga; Luisa Ugedo; Carl Sikkema; Charles W Wilkinson; Murray A Raskind
Journal:  Neuropharmacology       Date:  2015-09-08       Impact factor: 5.250

Review 4.  Depressive symptoms in neurodegenerative diseases.

Authors:  Miquel Baquero; Nuria Martín
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

5.  The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.

Authors:  Florindo Stella; Orestes Vicente Forlenza; Jerson Laks; Larissa Pires de Andrade; Michelle A Ljubetic Avendaño; Elisandra Villela Gasparetto Sé; João de Castilho Cação; Constantine G Lyketsos; Kate de Medeiros
Journal:  Int Psychogeriatr       Date:  2013-06-14       Impact factor: 3.878

6.  Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.

Authors:  Julia J Hsiao; Edmond Teng
Journal:  Neurodegener Dis Manag       Date:  2013

Review 7.  Behavioral and psychological symptoms in Alzheimer's disease.

Authors:  Xiao-Ling Li; Nan Hu; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

Review 8.  The Roles of Exercise and Yoga in Ameliorating Depression as a Risk Factor for Cognitive Decline.

Authors:  Danielle C Mathersul; Simon Rosenbaum
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-01       Impact factor: 2.629

9.  Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.

Authors:  Simon Forstmeier; Andreas Maercker
Journal:  BMC Psychiatry       Date:  2015-11-17       Impact factor: 3.630

10.  The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.

Authors:  Roberta W Scherer; Lea Drye; Jacobo Mintzer; Krista Lanctôt; Paul Rosenberg; Nathan Herrmann; Prasad Padala; Olga Brawman-Mintzer; William Burke; Suzanne Craft; Alan J Lerner; Allan Levey; Anton Porsteinsson; Christopher H van Dyck
Journal:  Trials       Date:  2018-01-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.